IBDEI0EV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6397,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,6398,0)
 ;;=I15.8^^53^410^5
 ;;^UTILITY(U,$J,358.3,6398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6398,1,3,0)
 ;;=3^Hypertension,Secondary
 ;;^UTILITY(U,$J,358.3,6398,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,6398,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,6399,0)
 ;;=I15.0^^53^410^4
 ;;^UTILITY(U,$J,358.3,6399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6399,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,6399,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,6399,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,6400,0)
 ;;=I70.1^^53^410^1
 ;;^UTILITY(U,$J,358.3,6400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6400,1,3,0)
 ;;=3^Atherosclerosis of Renal Artery
 ;;^UTILITY(U,$J,358.3,6400,1,4,0)
 ;;=4^I70.1
 ;;^UTILITY(U,$J,358.3,6400,2)
 ;;=^269760
 ;;^UTILITY(U,$J,358.3,6401,0)
 ;;=R03.0^^53^410^2
 ;;^UTILITY(U,$J,358.3,6401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6401,1,3,0)
 ;;=3^Elevated B/P Reading w/o HTN Diagnosis
 ;;^UTILITY(U,$J,358.3,6401,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,6401,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,6402,0)
 ;;=I95.1^^53^410^13
 ;;^UTILITY(U,$J,358.3,6402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6402,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,6402,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,6402,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,6403,0)
 ;;=I95.2^^53^410^11
 ;;^UTILITY(U,$J,358.3,6403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6403,1,3,0)
 ;;=3^Hypotension d/t Drugs
 ;;^UTILITY(U,$J,358.3,6403,1,4,0)
 ;;=4^I95.2
 ;;^UTILITY(U,$J,358.3,6403,2)
 ;;=^5008077
 ;;^UTILITY(U,$J,358.3,6404,0)
 ;;=I95.81^^53^410^14
 ;;^UTILITY(U,$J,358.3,6404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6404,1,3,0)
 ;;=3^Postprocedural Hypotension
 ;;^UTILITY(U,$J,358.3,6404,1,4,0)
 ;;=4^I95.81
 ;;^UTILITY(U,$J,358.3,6404,2)
 ;;=^5008078
 ;;^UTILITY(U,$J,358.3,6405,0)
 ;;=I95.9^^53^410^12
 ;;^UTILITY(U,$J,358.3,6405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6405,1,3,0)
 ;;=3^Hypotension,Unspec
 ;;^UTILITY(U,$J,358.3,6405,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,6405,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,6406,0)
 ;;=I16.0^^53^410^10
 ;;^UTILITY(U,$J,358.3,6406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6406,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,6406,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,6406,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,6407,0)
 ;;=I16.1^^53^410^7
 ;;^UTILITY(U,$J,358.3,6407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6407,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,6407,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,6407,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,6408,0)
 ;;=I16.9^^53^410^6
 ;;^UTILITY(U,$J,358.3,6408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6408,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,6408,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,6408,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,6409,0)
 ;;=B25.9^^53^411^5
 ;;^UTILITY(U,$J,358.3,6409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6409,1,3,0)
 ;;=3^CMV Disease,Unspec
 ;;^UTILITY(U,$J,358.3,6409,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,6409,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,6410,0)
 ;;=I30.1^^53^411^7
 ;;^UTILITY(U,$J,358.3,6410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6410,1,3,0)
 ;;=3^Infective Pericarditis
 ;;^UTILITY(U,$J,358.3,6410,1,4,0)
 ;;=4^I30.1
